The Oakmark Funds are advised by Harris Associates L.P. an autonomous subsidiary of Natixis Investment Managers, L.P.
Learn more about the principles and philosophy behind our funds at HarrisAssoc.com.
Partner and Co-CIO-International Equities
Tony Coniaris has been a manager of the Oakmark Global Fund and the Oakmark Global Select Fund since 2016. He was a manager Oakmark Select Fund from 2013 to 2023. He is also the co-chief investment officer for international equities at Harris Associates and an executive vice president of the Oakmark Funds.
He started at Harris Associates as a research associate in 1999 and became an analyst in 2003.
Mr. Coniaris received an M.B.A. from Northwestern University (2005) and a B.A. in business/economics from Wheaton College (1999).
News
March 7, 2025
Mike Manelli, Partner and co-portfolio manager of the Oakmark International Fund and the Oakmark International Small Cap Fund, will retire at year-end 2025 –...
Insights
December 12, 2024
Some companies are issuing shares and some are repurchasing them – why it all makes sense right now.
News
September 26, 2024
Chairman and Portfolio Manager Tony Coniaris talked about what falling interest rates mean for financial holdings during a CNBC “Money Movers” interview.
At Oakmark, we don’t have an opinion about how equities will perform this year, if a recession will start or if the political parties will produce pro-growth candidates during the next election cycle. As long-term investors, we don’t think it matters.
Commentary
Oakmark Global Fund: First Calendar Quarter 2025
March 31, 2025
The Fund had a strong quarter; a financial holding was a top contributor, while a technology company was a top detractor.
Oakmark Global Select Fund: First Calendar Quarter 2025
March 31, 2025
The Fund had a strong quarter; a financial holding was a top contributor, while a technology company was a top detractor.
Oakmark Global Fund: Fourth Calendar Quarter 2024
December 31, 2024
A top contributor to the Fund’s performance was a U.S.-headquartered consumer finance company, while a Germany-headquartered agriculture and pharma company was a top detractor.